Molecular Cancer

Table 1 Correlation between circSMARCC1 expression and clinicopathological features in plasma from patients with BPH (n = 39) and PCa (n = 39)

From: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling

Characteristic		N	circSMARCC1		χ2	P-value
Characteristic		N	low	high	χ2	P-value
Type	BPH	39	29	10	13.206	<0.001***
Type	PCa	39	13	26	13.206	<0.001***
Age	≤ 67	21	8	13	0.464	0.496
Age	>67	18	5	13	0.464	0.496
PSA	≤ 10	14	7	7	2.730	0.098
PSA	>10	25	6	19	2.730	0.098
Gleason score	ISUP ≤3	19	10	9	6.209	0.013*
Gleason score	ISUP>3	20	3	17	6.209	0.013*
T stage	T1–2	22	11	11	6.309	0.012*
T stage	T3–4	17	2	15	6.309	0.012*

Abbreviations: PCa Prostate cancer, BPH Benign prostatic hyperplasia, PSA Prostate specific antigen, *p < 0.05, ***p < 0.001

Back to article page

ISSN: 1476-4598

Contact us

General enquiries: journalsubmissions@springernature.com